Norgine

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 333: trim(): Passing null to parameter #1 ($string) of type string is deprecated

E_DEPRECATED Error in file �functions_general.php� at line 186: Function utf8_encode() is deprecated

Norgine is a European specialist pharmaceutical company that has been established for over 100 years. In 2014, Norgineâ€™s total revenue was â‚¬296 million and the company employs over 1,000 people. Norgine provides expertise and â€˜know howâ€™ in Europe to develop, manufacture and market products that offer real value to healthcare professionals, payers and patients. Norgineâ€™s approach and infrastructure is integrated and focused upon ensuring that Norgine wins partnership opportunities for growth. Norgine is headquartered in the Netherlands and its global operations are based in Amsterdam and in Harefield, UK. Norgine owns a R&D site in Hengoed, Wales and two manufacturing sites, one in Hengoed, Wales and one in Dreux, France.

Keywords:

Date	News
2020-02-12	NORGINE B.V. ENTERS INTO EXCLUSIVE LICENCE AND DISTRIBUTION AGREEMENTS FOR THE COMMERCIALISATION OF PLENVUÂ® IN A NUMBER...
2019-10-23	UEG Week exhibition celebrates 50 years of colonoscopy in preventing and diagnosing gastrointestinal diseases, including...
2019-10-22	HEAD-TO-HEAD STUDY SHOWS ORAL FERRIC MALTOL (FERACCRUÂ®) MAY BE AN ALTERNATIVE TREATMENT TO INTRAVENOUS (IV) FERRIC IRON...
2019-09-09	SPEPHARM AG WINS CASE AGAINST EISAI INC. IN UNITED STATES DISTRICT COURT FOR DISTRICT OF DELAWARE
2019-06-19	NORGINE RECOGNISED FOR EXCELLENCE IN HEALTH AND SAFETY WITH RoSPA GOLD MEDAL AWARD FIFTH YEAR IN A ROW
2019-06-18	NEW STUDY SHOWS RIFAXIMIN SIGNIFICANTLY REDUCED THE NUMBER AND LENGTH OF HOSPITALISATIONS IN PATIENTS WITH OVERT HEPATIC...
2019-06-10	NORGINE MARKS 50TH ANNIVERSARY OF PHARMACEUTICAL MANUFACTURING SITE IN WALES
2019-04-15	NEW REAL WORLD STUDY SHOWS RIFAXIMIN-Î± SIGNIFICANTLY REDUCED HOSPITALISATION IN PATIENTS WITH OVERT HEPATIC ENCEPHALOPA...
2019-04-04	NORGINE NEW STUDY HIGHLIGHTS NEED TO INCREASE PUBLIC UNDERSTANDING OF IMPORTANT ROLE OF COLONOSCOPY IN PREVENTING AND DI...
2019-03-06	NORGINE ENTERS INTO A NEW PARTNERSHIP WITH ADACYTE THERAPEUTICS TO COMMERCIALISE ADACOLUMNÂ® IN SWITZERLAND

Date

News

2020-02-12

NORGINE B.V. ENTERS INTO EXCLUSIVE LICENCE AND DISTRIBUTION AGREEMENTS FOR THE COMMERCIALISATION OF PLENVUÂ® IN A NUMBER...

2019-10-23

UEG Week exhibition celebrates 50 years of colonoscopy in preventing and diagnosing gastrointestinal diseases, including...

2019-10-22

HEAD-TO-HEAD STUDY SHOWS ORAL FERRIC MALTOL (FERACCRUÂ®) MAY BE AN ALTERNATIVE TREATMENT TO INTRAVENOUS (IV) FERRIC IRON...

2019-09-09

SPEPHARM AG WINS CASE AGAINST EISAI INC. IN UNITED STATES DISTRICT COURT FOR DISTRICT OF DELAWARE

2019-06-19

NORGINE RECOGNISED FOR EXCELLENCE IN HEALTH AND SAFETY WITH RoSPA GOLD MEDAL AWARD FIFTH YEAR IN A ROW